Join to view full profile
6410 Fannin StSte 450Houston, TX 77030
Phone+1 713-486-3100
Fax+1 713-512-2246
Dr. Skaug is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Rheumatology, 2018
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2016
University of Texas Southwestern Medical SchoolClass of 2013
Certifications & Licensure
TX State Medical License 2015 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 1 citationsPulmonary arterial hypertension susceptibility and mortality among patients with systemic sclerosis with the DNASE1L3 rs35677470 (Arg206Cys) variant.Brian Skaug, Stefano Rodolfi, Christopher P Denton, Ami A Shah, Bich Na Choi
Annals of the Rheumatic Diseases. 2026-10-01 - Determinants of Body Mass Index in Early Systemic Sclerosis: Implications for Nutritional Risk Stratification.Ali Y Ayla, Meng Zhang, Bingrui Chen, Claudia Pedroza, Brian Skaug
Arthritis Care & Research. 2026-06-22 - Early gastrointestinal manifestations predict disease progression and mortality in patients with systemic sclerosis.Ali Y Ayla, Ashish P Balar, Ernesto Calderon Martinez, Bingrui Chen, Claudia Pedroza
Rheumatology. 2026-06-03
Journal Articles
- Foxo3 Promotes Apoptosis of B Cell Receptor–Stimulated Immature B Cells, Thus Limiting the Window for Receptor EditingBrian Skaug, Evan Barrios, Diego H Castrillon, The Journal of Immunology
Grant Support
- Pulmonary arterial hypertension susceptibility in systemic sclerosis patients with the DNASE1L3 R206C variantUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2026–2028
- Pathogenic effects of the DNASE1L3 R206C variant in systemic sclerosisUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: